Delivery Order SPE2DB22D2006-SPE2DB24FW2SK
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FFLW7, is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,844.94 and is a Firm Fixed Price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract does not have a set-aside designation. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen has...
This federal contract award is for the delivery of 4,566,749,454 units of Ondansetron HCL 8 mg tablets. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has a total ceiling value of $1,607.18 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999...
This federal contract award is for the delivery of 4,565,470,676 units of Ondansetron HCL 8 mg tablets by Amerisourcebergen Drug Corp to the U.S. government. The contract, valued at $7,519.33, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This federal contract award, valued at $5,514.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,066,677 units of Ondansetron HCL 8 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 10, 2024. It is not designated as a set-aside contract. As a leading provider of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,930.42 delivery order contract is for the supply of 4565111977 - Ondansetron HCL 8 mg Tablets in 30-count packages. The contract has an ultimate completion date of July 11, 2024 and is a firm fixed-price contract type. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $2,083.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,148,202 units of the pharmaceutical product Ondansetron HCL 8 mg Tablet, with a completion date of May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $4,368.15. The contract is a delivery order with a firm fixed price pricing type, with an ultimate completion date of May 28, 2025. There is no set-aside designation mentioned for this contract....
This federal contract award is for the delivery of 4,563,337,505 units of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $3,198.52 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 16, 2024 with a completion date of January 17, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $7,107.84 firm fixed-price delivery order was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 14, 2024. The contract has an ultimate completion date of June 17, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award, identified as SPE2DB22D2211|SPE2DB25FRWGZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,092,728 units of Ondansetron HCL 4 mg tablets in 30-count packages, with a ceiling value of $7,824.36. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 1, 2025....